Abstract
The treatment of stage I non-seminomatous germ cell (NSGCT) tumor includes retroperitoneal lymph node dissection (RPLND) for patients with high-risk tumor characteristics and for those patients with residual masses after primary chemotherapy. Laparoscopic RPLND (L-RPLND) was initially performed to reduce the morbidity associated with open RPLND (O-RPLND) and at the same time maintain the staging and therapeutic benefits of lymph node removal. However, L-RPLND is a challenging procedure and requires extensive experience with laparoscopic techniques including laparoscopic control of bleeding. Robotic RPLND (R-RPLND) provides enhanced endoscopic visibility, improved dexterity, and superior control of bleeding over L-RPLND. The robotic platform has allowed for a full bilateral RPLND to be performed in one setting without the need to reposition the patient. The bilateral approach as well as improved vascular control has permitted R-RPLND to be expanded to patients with post chemotherapy masses.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Daugaard G, Petersen PM, Rorth M. Surveillance in stage I testicular cancer. APMIS. 2003;111:76–85.
Amato RJ, Ro JY, Ayala AG, Swanson DA. Risk-adapted treatment for patients with clinical stage I nonseminomatous germ cell tumor of the testis. Urology. 2003;63(1):144–9.
Hermans BP, Sweeney CP, Foster RS, Einhorn LE, Donohue JP. Risk of systemic metastases in clinical stage I nonseminoma germ cell testis tumor managed by retroperitoneal lymph node dissection. J Urol. 2000;163:1721–4.
Donohue JP, Foster RS. Retroperitoneal lymphadenectomy in staging and treatment. The development of nerve-sparing technique. Urol Clin North Am. 1998;25(3):461–8.
Babaian R, Bracken RB, Johnson DE. Complications of transabdominal retroperitoneal lymphadenectomy. Urology. 1981;17:126–8.
Baniel J, Foster RS, Rowland RG, Bihrle R, Donohue JP. Complications of retroperitoneal lymph node dissection. J Urol. 1994;152:424–7.
National Comprehensive Cancer Network clinical practice guidelines in oncology. Testicular cancer-nonseminoma, Version 2; 2016. https://www.nccn.org.
European Association of Urology. European Association of Urology guidelines on testicular cancer. Eur Urol. 2011;60:304–19.
Bhayani S, Ong A, Oh W, Kantoff PW, Kavoussi LR. Laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer: a long term update. Urology. 2003;62:324–7.
Gerber G, Bissada N, Hulbert J, Kavoussi LR, Moore RG, Kantoff PW, et al. Laparoscopic retroperitoneal lymphadenectomy: multi-institutional analysis. J Urol. 1994;152:1188–92.
Steiner H, Peschel R, Janetschek G, Höltl L, Berger AP, Bartsch G, et al. Long term results of laparoscopic retroperitoneal lymph node dissection: a single center 10 year experience. Urology. 2004;63:550–5.
Rassweiler J, Frede T, Lenz E, Seemann O, Alken P. Long term experience with laparoscopic retroperitoneal lymph node dissection in the management of low stage testis cancer. Eur Urol. 2000;37:251–60.
Rassweiler J, Scheitlin W, Heidenreich A, Laguna MP, Janetschek G. Laparoscopic retroperitoneal lymph node dissection: does it still have a role in the management of clinical stage I nonseminomatuous testis cancer? A European perspective. Eur Urol. 2008;54:1004–19.
Nielsen M, Guilherme L, Porter J, Porter J, Cadeddu JA, Tuerk I, et al. Oncologic efficacy of laparoscopic RPLND in treatment of clinical stage I nonseminomatous germ cell testicular cancer. Urology. 2007;70:1168–72.
Davol P, Sumfest J, Rukstalis D. Robot-assisted laparoscopic retroperitoneal lymph node dissection. Urology. 2006;67:199.e7–8.
Williams S, Lau C, Josephson D. Initial series of roboti-assisted laparoscopic retroperitoneal lymph node dissection for clinical stage I nonseminomatous germ cell testicular cancer. Eur Urol. 2011;60:1299–302.
Cheney S, Andrews PE, Leibovich BC, Castle EP. Robot-assisted retroperitoneal lymph noded dissection: technique and initial case series of 18 patients. BJUI. 2015;115:114–20.
Pearce S, Golan S, Gorin M, Luckenbaugh AN, Williams SB, Ward JF, et al. Safety and early oncologic effectiveness of primary robotic retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer. Eur Urol. 2017;71(3):476–82.
Stepanian S, Patel M, Porter J. Robot-assisted laparoscopic retroperitoneal lymph node dissection for testicular cancer: evolution of the technique. Eur Urol. 2016;70:661–7.
Harris K, Gorin M, Ball MW, Pierorazio PM, Allaf ME. A comparative analysis of robotic and laparoscopic retroperitoneal lymph node dissection for testicular cancer. BJUI. 2015;116:920–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Porter, J.R. (2018). Robot-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection in Testicular Tumor. In: Hemal, A., Menon, M. (eds) Robotics in Genitourinary Surgery. Springer, Cham. https://doi.org/10.1007/978-3-319-20645-5_60
Download citation
DOI: https://doi.org/10.1007/978-3-319-20645-5_60
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-20644-8
Online ISBN: 978-3-319-20645-5
eBook Packages: MedicineMedicine (R0)